Literature DB >> 16625352

MRI features of neurodegenerative Langerhans cell histiocytosis.

N Martin-Duverneuil1, A Idbaih, K Hoang-Xuan, J Donadieu, T Genereau, R Guillevin, J Chiras.   

Abstract

CNS complications of LCH include "space occupying" lesions corresponding to histiocytic granulomas and "neurodegenerative" presentation (ND-LCH) characterized by a progressive cerebellar ataxia. Studies analyzing specifically the MRI presentation of ND-LCH are scarce. We present here the MRIs of 13 patients registered as isolated ND-LCH. Posterior fossa was involved in 12 patients (92%), showing a symmetrical T2 hyperintensity of the cerebellar white matter areas in seven cases with a circumscribed T1 hyperintensity of the dentate nuclei in five cases, definite hyperintense T2 areas in the adjacent pontine tegmentum white matter in nine cases associated with a hyperintensity of the pontine pyramidal tracts in four cases. A cerebellar atrophy was noted in eight cases. The supratentorial region was involved in 11 patients, showing T2 hyperintense lesions in the cerebral white matter in eight cases and a discrete symmetrical T1 hyperintense signal in the globus pallidus in eight patients. A diffuse cortical atrophy was present in three cases and a marked focal atrophy of the corpus callosum in three cases. This series allows us to establish a not previously reported evocative semeiologic MR presentation to precisely orientate to the diagnosis of the pure neurodegenerative form of LCH.

Entities:  

Mesh:

Year:  2006        PMID: 16625352     DOI: 10.1007/s00330-006-0200-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  21 in total

1.  Cerebellar and basal ganglion involvement in Langerhans cell histiocytosis.

Authors:  I Saatci; O Baskan; M Haliloglu; U Aydingoz
Journal:  Neuroradiology       Date:  1999-06       Impact factor: 2.804

2.  Hyperintense basal ganglia on T1-weighted MR in a patient with Langerhans cell histiocytosis.

Authors:  Y Miaux; F Keime; N Martin-Duverneuil; C Cognard; D Savin; J Chiras
Journal:  AJNR Am J Neuroradiol       Date:  1996 Jun-Jul       Impact factor: 3.825

Review 3.  Primary Langerhans' cell histiocytosis of the central nervous system with fatal outcome. Case report.

Authors:  A Vital; H Loiseau; G Kantor; C Vital; F Cohadon
Journal:  J Neurosurg       Date:  1996-12       Impact factor: 5.115

4.  Brain MR in patients with Langerhans cell histiocytosis: findings and enhancement with Gd-DTPA.

Authors:  N S Rosenfield; J Abrahams; D Komp
Journal:  Pediatr Radiol       Date:  1990

5.  Cerebral and brain stem Langerhans cell histiocytosis.

Authors:  W H Breidahl; F J Ives; M S Khangure
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

6.  Langerhans cell histiocytosis involving the corpus callosum and cerebellum: gadolinium-enhanced MRI.

Authors:  J M Strottmann; L E Ginsberg; C Stanton
Journal:  Neuroradiology       Date:  1995-05       Impact factor: 2.804

7.  Neuropathology of CNS disease in Langerhans cell histiocytosis.

Authors:  Nicole Grois; Daniela Prayer; Helmut Prosch; Hans Lassmann
Journal:  Brain       Date:  2005-02-10       Impact factor: 13.501

8.  A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group.

Authors: 
Journal:  Arch Dis Child       Date:  1996-07       Impact factor: 3.791

9.  Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study.

Authors:  Jean Donadieu; Maria-Alejandra Rolon; Caroline Thomas; Laurence Brugieres; Dominique Plantaz; Jean François Emile; Didier Frappaz; Michel David; Raja Brauner; Thierry Genereau; Dominique Debray; Sylvie Cabrol; Marie-Anne Barthez; Khé Hoang-Xuan; Michel Polak
Journal:  J Pediatr       Date:  2004-03       Impact factor: 4.406

10.  Retinoic acid therapy in "degenerative-like" neuro-langerhans cell histiocytosis: a prospective pilot study.

Authors:  Ahmed Idbaih; J Donadieu; M A Barthez; F Geissmann; Y Bertrand; O Hermine; L Brugières; T Genereau; C Thomas; K Hoang-Xuan
Journal:  Pediatr Blood Cancer       Date:  2004-07       Impact factor: 3.167

View more
  16 in total

1.  [Cerebellar syndromes in Langerhans' cell histiocytosis].

Authors:  M Bös; C Grothe; H Urbach; R Schröder
Journal:  Nervenarzt       Date:  2007-04       Impact factor: 1.214

2.  Paediatric neuroradiological aspects of Langerhans cell histiocytosis.

Authors:  Philippe Demaerel; Stefaan Van Gool
Journal:  Neuroradiology       Date:  2007-11-06       Impact factor: 2.804

3.  The dentate nucleus in children: normal development and patterns of disease.

Authors:  Aoife McErlean; Khaled Abdalla; Veronica Donoghue; Stephanie Ryan
Journal:  Pediatr Radiol       Date:  2010-01-28

Review 4.  Imaging of Histiocytosis in the Era of Genomic Medicine.

Authors:  Hyesun Park; Mizuki Nishino; Jason L Hornick; Eric D Jacobsen
Journal:  Radiographics       Date:  2018-11-30       Impact factor: 5.333

5.  The cognitive spectrum in neurodegenerative Langerhans cell histiocytosis.

Authors:  Loïc Le Guennec; Caroline Decaix; Jean Donadieu; Maria Santiago-Ribeiro; Nadine Martin-Duverneuil; Richard Levy; Daniel Delgadillo; Aurélie Kas; Aurélie Drier; Laurent Magy; Eleonore Bayen; Khe Hoang-Xuan; Ahmed Idbaih
Journal:  J Neurol       Date:  2014-05-22       Impact factor: 4.849

6.  Neurodegeneration in the course of Langerhans cell histiocytosis.

Authors:  F Spagnolo; E Leopizzi; R Cardamone; M Falautano; V Martinelli; G Comi; M A Volonté
Journal:  Neurol Sci       Date:  2011-07-09       Impact factor: 3.307

7.  Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.

Authors:  Dragan A Stojanov; Aleksandra Aracki-Trenkic; Slobodan Vojinovic; Daniela Benedeto-Stojanov; Srdjan Ljubisavljevic
Journal:  Eur Radiol       Date:  2015-06-25       Impact factor: 5.315

Review 8.  Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.

Authors:  Dragan Stojanov; Aleksandra Aracki-Trenkic; Daniela Benedeto-Stojanov
Journal:  Neuroradiology       Date:  2016-02-12       Impact factor: 2.804

9.  Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease.

Authors:  Shinsaku Imashuku; Naoto Fujita; Yoko Shioda; Haruyoshi Noma; Shiro Seto; Toshinori Minato; Kazuo Sakashita; Nobuhiro Ito; Ryoji Kobayashi; Akira Morimoto
Journal:  Int J Hematol       Date:  2014-12-10       Impact factor: 2.490

10.  Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside.

Authors:  Carl E Allen; Ricardo Flores; Ronald Rauch; Robert Dauser; Jeffrey C Murray; Diane Puccetti; David A Hsu; Paul Sondel; Maxine Hetherington; Stan Goldman; Kenneth L McClain
Journal:  Pediatr Blood Cancer       Date:  2010-03       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.